{"id":1253,"date":"2016-08-22T13:18:04","date_gmt":"2016-08-22T11:18:04","guid":{"rendered":"http:\/\/haavind.local\/en\/2016\/08\/22\/haavind-pharma-report\/"},"modified":"2025-08-29T09:54:11","modified_gmt":"2025-08-29T09:54:11","slug":"haavind-pharma-report","status":"publish","type":"post","link":"https:\/\/haavind.no\/en\/haavind-pharma-report\/","title":{"rendered":"New edition of Haavind\u2019s Pharma Report"},"content":{"rendered":"\t<div class=\"template-post alignwide wp-block-dekode-hero\">\n\t\t<div class=\"hero__inner\">\n\t\t\t<div class=\"hero__inner_blocks\">\n\t\t\t\t\n<h1 class=\"wp-block-post-title\">New edition of Haavind\u2019s Pharma Report<\/h1>\n\n\n<p>Haavind\u2019s Healthcare and Life Science team has published the latest edition of their Pharma Report. The report provides a retrospective overview of selected legal developments in Norway which occurred during the first half of 2016 and which are relevant for the pharmaceutical industry. <\/p>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div><\/div>\n\t\t\t\t\t<div class=\"post-meta\">\n\t\t\t\t\t\t<span class=\"info-small\">22 August, 2016 \u00b7 2 min. reading time<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\n\n<div class=\"alignleft wp-block-haavind-byline\">\n\t\t\t\t<span class=\"author-tag\">Contact person<\/span>\n\t\t\t\t<div class=\"authors\"><a href=\"https:\/\/haavind.no\/en\/people\/hakon-austdal\/\" class=\"t2-byline__author-link\">\n\t\t\t\t<div class=\"author-inner\">\n\t\t\t\t\t<div class=\"author-inner__image\"><img loading=\"lazy\" decoding=\"async\" width=\"233\" height=\"300\" src=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-233x300.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-233x300.jpg 233w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-768x989.jpg 768w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-795x1024.jpg 795w, https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal.jpg 800w\" sizes=\"(max-width: 233px) 100vw, 233px\" \/><\/div>\n\t\t\t\t\t<div>\n\t\t\t\t\t\t<span class=\"name\">H\u00e5kon Austdal<\/span>\n\t\t\t\t\t\t<span>Specialist Counsel<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/a><\/div>\n\t\t\t\t<div class=\"topics\">\n\t\t\t\t<span>Topics<\/span>\n\t\t\t\t<div><a class=\"tag-link\" href=\"https:\/\/haavind.no\/en\/expertise\/intellectual-property-rights\">Intellectual property rights<\/a><a class=\"tag-link\" href=\"https:\/\/haavind.no\/en\/kompetanse\/bransje\/healthcare-and-life-science\/\">Healthcare and life science<\/a><\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\n\n<p>Haavind\u2019s Healthcare and Life Science team has published the latest edition of their Pharma Report. The report provides a retrospective overview of selected legal developments in Norway which occurred during the first half of 2016 and which are relevant for the pharmaceutical industry. <\/p>\n\n\n\n<p>Our Pharma Report is made available in English as an easy-to-read e-book, <a href=\"https:\/\/indd.adobe.com\/view\/bb8bbe02-88ea-4b0d-a8fe-f84555609814\">accessed here<\/a>.<\/p>\n\n\n\n<p>If you wish to receive future editions of our Pharma Report as well as other news and updates from our Healthcare and Life Science team, please <a href=\"https:\/\/www.anpdm.com\/form\/41405F4A78484B5D467140\/434A5D4A7041405D4471\">sign up for our newsletter<\/a>.<\/p>\n\n\n\t<div \n\t\tclass=\"template-post alignwide wp-block-haavind-block-contact-people\" id=\"contact\"\t\t>\n\t\t<h2 class=\"post-featured-title\">Contact us<\/h2>\n\t\t<div class=\"block-contact-people-list\">\n\t\t\t\n<div class=\"t2-featured-content-layout alignwide wp-block-t2-featured-content-layout\">\n<div class=\"t2-featured-single-post t2-featured-content is-post-type-person sector-fisheries-and-aquaculture sector-healthcare-and-life-science sector-technology sector-retail speciality-food speciality-intellectual-property-rights role-specialist-counsel wp-block-t2-featured-single-post\">\n<div class=\"wp-block-group alignfull post-featured-image is-layout-flow wp-block-group-is-layout-flow\">\n\t<a class=\"t2-post-link wp-block-t2-post-link\" href=\"https:\/\/haavind.no\/en\/people\/hakon-austdal\/\">\n\t<figure style=\"--t2-focal-point: 50% 50%\" class=\"t2-post-featured-image has-image-ratio-3-4 wp-block-t2-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"795\" height=\"1024\" src=\"https:\/\/haavind.no\/content\/uploads\/sites\/2\/2016\/04\/Ha\u030akon-Austdal-795x1024.jpg\" class=\"attachment-large size-large wp-post-image\" alt=\"\" \/><\/figure>\n\t<\/a>\n<\/div>\n\n\n<div class=\"wp-block-group alignfull post-featured-content is-layout-flow wp-block-group-is-layout-flow\">\n\t<a class=\"t2-post-link wp-block-t2-post-link\" href=\"https:\/\/haavind.no\/en\/people\/hakon-austdal\/\"><h2 class=\"t2-post-title wp-block-t2-post-title\">H\u00e5kon Austdal<\/h2><\/a>\n\t<div class=\"taxonomy-role wp-block-post-terms\"><a href=\"https:\/\/haavind.no\/en\/role\/specialist-counsel\/\" rel=\"tag\">Specialist Counsel<\/a><\/div>\n\t<div class=\"card-info wp-block-t2-people-meta\"><div class=\"card-info__post-meta meta-key-people_email\"><a href=\"mailto:h.austdal@haavind.no\">h.austdal@haavind.no<\/a><\/div><div class=\"card-info__post-meta meta-key-people_phone\"><a href=\"tel:+47 920 19 526\">+47 920 19 526<\/a><\/div><\/div>\n<\/div>\n\n<\/div>\n<\/div>\n\t\t<\/div>\n\t\t\t<\/div>\n\t","protected":false},"excerpt":{"rendered":"<p>Haavind\u2019s Healthcare and Life Science team has published the latest edition of their Pharma Report. The report provides a retrospective overview of selected legal developments in Norway which occurred during the first half of 2016 and which are relevant for the pharmaceutical industry. <\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"sector":[7],"speciality":[24],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.2 (Yoast SEO v24.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>New edition of Haavind\u2019s Pharma Report - Haavind EN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/haavind.no\/en\/haavind-pharma-report\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New edition of Haavind\u2019s Pharma Report\" \/>\n<meta property=\"og:description\" content=\"Haavind\u2019s Healthcare and Life Science team has published the latest edition of their Pharma Report. The report provides a retrospective overview of selected legal developments in Norway which occurred during the first half of 2016 and which are relevant for the pharmaceutical industry.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/haavind.no\/en\/haavind-pharma-report\/\" \/>\n<meta property=\"og:site_name\" content=\"Haavind EN\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-22T11:18:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-29T09:54:11+00:00\" \/>\n<meta name=\"author\" content=\"Camilla\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Camilla\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/haavind.no\/en\/haavind-pharma-report\/\",\"url\":\"https:\/\/haavind.no\/en\/haavind-pharma-report\/\",\"name\":\"New edition of Haavind\u2019s Pharma Report - Haavind EN\",\"isPartOf\":{\"@id\":\"https:\/\/haavind.no\/en\/#website\"},\"datePublished\":\"2016-08-22T11:18:04+00:00\",\"dateModified\":\"2025-08-29T09:54:11+00:00\",\"author\":{\"@id\":\"https:\/\/haavind.no\/en\/#\/schema\/person\/0701bc9d64854d65dd3e774b33118f6d\"},\"breadcrumb\":{\"@id\":\"https:\/\/haavind.no\/en\/haavind-pharma-report\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/haavind.no\/en\/haavind-pharma-report\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/haavind.no\/en\/haavind-pharma-report\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Intellectual property rights\",\"item\":\"https:\/\/haavind.no\/en\/kompetanse\/fagomrade\/intellectual-property-rights\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New edition of Haavind\u2019s Pharma Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/haavind.no\/en\/#website\",\"url\":\"https:\/\/haavind.no\/en\/\",\"name\":\"Haavind EN\",\"description\":\"-\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/haavind.no\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/haavind.no\/en\/#\/schema\/person\/0701bc9d64854d65dd3e774b33118f6d\",\"name\":\"Camilla\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haavind.no\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/056dd7829c9994cb22af97c497641075?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/056dd7829c9994cb22af97c497641075?s=96&d=mm&r=g\",\"caption\":\"Camilla\"},\"url\":\"https:\/\/haavind.no\/en\/author\/camilla\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New edition of Haavind\u2019s Pharma Report - Haavind EN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/haavind.no\/en\/haavind-pharma-report\/","og_locale":"en_US","og_type":"article","og_title":"New edition of Haavind\u2019s Pharma Report","og_description":"Haavind\u2019s Healthcare and Life Science team has published the latest edition of their Pharma Report. The report provides a retrospective overview of selected legal developments in Norway which occurred during the first half of 2016 and which are relevant for the pharmaceutical industry.","og_url":"https:\/\/haavind.no\/en\/haavind-pharma-report\/","og_site_name":"Haavind EN","article_published_time":"2016-08-22T11:18:04+00:00","article_modified_time":"2025-08-29T09:54:11+00:00","author":"Camilla","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Camilla","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/haavind.no\/en\/haavind-pharma-report\/","url":"https:\/\/haavind.no\/en\/haavind-pharma-report\/","name":"New edition of Haavind\u2019s Pharma Report - Haavind EN","isPartOf":{"@id":"https:\/\/haavind.no\/en\/#website"},"datePublished":"2016-08-22T11:18:04+00:00","dateModified":"2025-08-29T09:54:11+00:00","author":{"@id":"https:\/\/haavind.no\/en\/#\/schema\/person\/0701bc9d64854d65dd3e774b33118f6d"},"breadcrumb":{"@id":"https:\/\/haavind.no\/en\/haavind-pharma-report\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/haavind.no\/en\/haavind-pharma-report\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/haavind.no\/en\/haavind-pharma-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Intellectual property rights","item":"https:\/\/haavind.no\/en\/kompetanse\/fagomrade\/intellectual-property-rights\/"},{"@type":"ListItem","position":2,"name":"New edition of Haavind\u2019s Pharma Report"}]},{"@type":"WebSite","@id":"https:\/\/haavind.no\/en\/#website","url":"https:\/\/haavind.no\/en\/","name":"Haavind EN","description":"-","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/haavind.no\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/haavind.no\/en\/#\/schema\/person\/0701bc9d64854d65dd3e774b33118f6d","name":"Camilla","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haavind.no\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/056dd7829c9994cb22af97c497641075?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/056dd7829c9994cb22af97c497641075?s=96&d=mm&r=g","caption":"Camilla"},"url":"https:\/\/haavind.no\/en\/author\/camilla\/"}]}},"_links":{"self":[{"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/posts\/1253"}],"collection":[{"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/comments?post=1253"}],"version-history":[{"count":2,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/posts\/1253\/revisions"}],"predecessor-version":[{"id":7173,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/posts\/1253\/revisions\/7173"}],"wp:attachment":[{"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/media?parent=1253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/categories?post=1253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/tags?post=1253"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/sector?post=1253"},{"taxonomy":"speciality","embeddable":true,"href":"https:\/\/haavind.no\/en\/wp-json\/wp\/v2\/speciality?post=1253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}